91.5%
disease-modifying therapyFabry disease68Ga-DOTATATEFabry cardiomyopathy
…R 57–70) years; 58% male; 50% classical phenotype. All received disease-modifying therapy. Focal 68Ga-DOTATATE uptake was present in all patients with he…
4articles mentioning treatments
4treatment mentions
1distinct treatments extracted
0%of mentions human-reviewed
Active filtersEntity: disease-modifying therapy ×
disease-modifying therapy
This treatment is selected. Its supporting articles are shown below.
Articles mentioning disease-modifying therapy
4 articles · page 1 of 1disease-modifying therapyocrelizumabnatalizumabofatumumabmultiple sclerosisrituximabneuromyelitis optica spectrum disorderGerman MS and Pregnancy RegistrymAb-BFDMT
…tive disease may benefit from early post partum reinitiation of disease-modifying therapy (DMT), but safety data to monoclonal antibody (mAb) use while b…
supportive caredisease-modifying therapypancreatic cancerchronic pancreatitisCPRAPgastroenterology
…nd fibrogenesis—clinical management remains largely anchored in supportive care rather than targeted pharmacologic intervention. For patients w…
77.7%
DMTdisease-modifying therapycladribinemultiple sclerosisMS
…e provides a compelling example of a disease-modifying therapy (DMT) that promotes both adherence and persistence, reinforcing its …